T-cell exhaustion in glioblastoma

per Woroniecka, Karolina, Fecci, Peter E.
Publicat a Oncotarget (2018)

4-1BB Agonism as a strategy to license immune checkpoint blockade in glioblastoma

per Woroniecka, Karolina, Fecci, Peter E.
Publicat a Oncoscience (2020)

Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma

per Woroniecka, Karolina, Fecci, Peter E
Publicat a Neuro Oncol (2020)

Immunotherapy of malignant brain tumors

per Mitchell, Duane A., Fecci, Peter E., Sampson, John H.
Publicat 2008

Regulatory T cells move in when gliomas say “I-DO”

per Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Publicat 2012

Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege

per Fecci, Peter E., Heimberger, Amy B., Sampson, John H.
Publicat a Clin Cancer Res (2014)

Checkpoint blockade therapy for functioning pituitary adenomas

per Lorrey, Selena J., Kemeny, Hanna R., Fecci, Peter E.
Publicat a Oncoscience (2020)

Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma

per Vlahovic, Gordana, Fecci, Peter E., Reardon, David, Sampson, John H.
Publicat a Neuro Oncol (2015)

Immunovirotherapy for the treatment of glioblastoma

per Cheema, Tooba A, Fecci, Peter E, Ning, Jianfang, Rabkin, Samuel D
Publicat 2014

Antibody-based immunotherapy for malignant glioma

per Gedeon, Patrick C., Riccione, Katherine A., Fecci, Peter E., Sampson, John H.
Publicat 2014

Brain immunology and immunotherapy in brain tumours

per Sampson, John H., Gunn, Michael D., Fecci, Peter E., Ashley, David M.
Publicat a Nat Rev Cancer (2019)

Flow Cytometric Identification of Tumor-Infiltrating Lymphocytes from Glioblastoma

per Woroniecka, Karolina, Chongsathidkiet, Pakawat, Elsamadicy, Aladine, Farber, Harrison, Cui, Xiuyu, Fecci, Peter E.
Publicat a Methods Mol Biol (2018)

T-cell Dysfunction in Glioblastoma: Applying a New Framework

per Woroniecka, Karolina I., Rhodin, Kristen E., Chongsathidkiet, Pakawat, Keith, Kristin A., Fecci, Peter E.
Publicat a Clin Cancer Res (2018)

Prospect of rindopepimut in the treatment of glioblastoma

per Elsamadicy, Aladine A., Chongsathidkiet, Pakawat, Desai, Rupen, Woroniecka, Karolina, Farber, S. Harrison, Fecci, Peter E., Sampson, John H.
Publicat a Expert Opin Biol Ther (2017)

Checkpoint inhibition and CAR T cells for the Treatment of Glioblastoma

per Shen, Steven H., Woroniecka, Karolina, Barbour, Andrew B., Fecci, Peter E., Sanchez-Perez, Luis, Sampson, John H.
Publicat a Expert Opin Biol Ther (2020)

Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage

per Yanamadala, Vijay, Walcott, Brian P., Fecci, Peter E., Rozman, Peter, Kumar, Jay I., Nahed, Brian V., Swearingen, Brooke
Publicat a J Clin Neurosci (2014)

The Safety of Available Immunotherapy for the Treatment of Glioblastoma

per Farber, S. Harrison, Elsamadicy, Aladine A., Atik, Fatih, Suryadevara, Carter M., Chongsathidkiet, Pakawat, Fecci, Peter E., Sampson, John H.
Publicat a Expert Opin Drug Saf (2017)

Immune suppression in gliomas

per Grabowski, Matthew M., Sankey, Eric W., Ryan, Katherine J., Chongsathidkiet, Pakawat, Lorrey, Selena J., Wilkinson, Daniel S., Fecci, Peter E.
Publicat a J Neurooncol (2020)

Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

per Cheema, Tooba A., Wakimoto, Hiroaki, Fecci, Peter E., Ning, Jianfang, Kuroda, Toshihiko, Jeyaretna, Deva S., Martuza, Robert L., Rabkin, Samuel D.
Publicat 2013

Immunotherapy for malignant glioma

per Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Publicat a Surg Neurol Int (2015)